JHX Investor Deadline Alert: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms

SAN FRANCISCO, Dec. 13, 2025 /PRNewswire/ — Global plaintiffs’ rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against James Hardie Industries plc (NYSE: JHX) is rapidly approaching: December 23, 2025. The lawsuit alleges that James Hardie and certain executives made materially false and misleading statements about the… Continue reading JHX Investor Deadline Alert: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms

Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

Expands Sobi’s pipeline with a highly differentiated new Phase 3 asset in Gout Acquisition expected to be highly accretive to Sobi’s mid- to long-term growth and margin trajectory STOCKHOLM, Dec. 13, 2025 /PRNewswire/ — Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage biotechnology company focused on developing… Continue reading Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

Fermi Inc. (FRMI) Shares Tank 33% Amid First Tenant Contract Termination — Hagens Berman Investigating

SAN FRANCISCO, Dec. 13, 2025 /PRNewswire/ — On December 12, 2025, investors in Fermi Inc. (NASDAQ: FRMI) saw the price of their shares crater about 33% after the company revealed that a prospective anchor tenant (“First Tenant”) for Fermi’s Project Matador (the company’s Advanced Energy and Intelligence Campus at Texas Tech University) terminated an agreement… Continue reading Fermi Inc. (FRMI) Shares Tank 33% Amid First Tenant Contract Termination — Hagens Berman Investigating

Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

Expands Sobi’s pipeline with a highly differentiated new Phase 3 asset in Gout Acquisition expected to be highly accretive to Sobi’s mid- to long-term growth and margin trajectory STOCKHOLM, Dec. 13, 2025 /PRNewswire/ — Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage biotechnology company focused on developing… Continue reading Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

TTW Reveals Top 50 Countries of the World as Best Travel Destinations for 2026

The 2026 list reflects how global travel is evolving—where cultural richness, accessibility, infrastructure readiness, and traveler confidence intersect. From established tourism powerhouses to fast-emerging destinations, the ranking offers a forward-looking snapshot of where the world is preparing to travel next. “The Top 50 Global Travel Destinations for 2026 captures the changing priorities of global travelers—where… Continue reading TTW Reveals Top 50 Countries of the World as Best Travel Destinations for 2026

Corboy & Demetrio Partner Conrad Nowak receives 2025 Volunteer of the Year Award

CHICAGO, Dec. 12, 2025 /PRNewswire/ — Corboy & Demetrio Partner Conrad Nowak received the prestigious Chicago Sister Cities International(CSCI) Volunteer of the Year Award at World Business Chicago’s annual Chicago International Gala on Nov. 14, 2025. The Award was given to Conrad by Chicago Mayor Brandon Johnson before a crowd of more than 800 people,… Continue reading Corboy & Demetrio Partner Conrad Nowak receives 2025 Volunteer of the Year Award

Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL

NEW YORK, Dec. 13, 2025 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public. So What: If you purchased Hormel… Continue reading Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL

Phemex co-hosts LONGITUDE, Spotlighting the Next Era of Crypto Security at Its 6th Anniversary

APIA, Samoa, 13 december 2025 /PRNewswire/ — Phemex, een crypto-uitwisseling voor gebruikers, organiseerde op 11 december met succes de 7e editie van LONGITUDE met Cointelegraph in het Rosewood Hotel in Abu Dhabi. Samen met de Abu Dhabi Finance Week bracht de bijeenkomst Web3-leiders en institutionele innovators bijeen voor een avond van strategische dialoog, ter gelegenheid van het… Continue reading Phemex co-hosts LONGITUDE, Spotlighting the Next Era of Crypto Security at Its 6th Anniversary

United Imaging Intelligence auf der RSNA 2025: Mit KI-Agenten die Medizin neu gestalten

SHANGHAI, 13. Dezember 2025 /PRNewswire/ — Unter dem Motto „Imaging the Individual” (wörtlich: Abbildung des Individuums) forderte die RSNA 2025 die radiologische Fachgemeinschaft dazu auf, neue Grenzen auszuloten und die Lücke zwischen personalisierter Versorgung und globalen Gesundheitsungleichheiten zu schließen. In diesem Jahr stellte United Imaging Intelligence (UII), die auf KI spezialisierte Tochtergesellschaft der United Imaging Group,… Continue reading United Imaging Intelligence auf der RSNA 2025: Mit KI-Agenten die Medizin neu gestalten

ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit

NEW YORK, Dec. 13, 2025 /PRNewswire/ —  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”) of the important January 26, 2026 lead plaintiff deadline. So what: If you purchased… Continue reading ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit